Silent malignancy in plain sight: a rare case of dual carcinomatous and sarcomatous transformation in a giant cervical polyp
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20264019Keywords:
Cervical polyp, Malignant transformation, Endometrial stromal sarcoma, Giant cervical polyp, Histopathology, Case reportAbstract
Cervical polyps are common benign gynecological lesions. Although malignant transformation is exceedingly rare (occurring in <1.7% of cases), it presents a distinct clinical challenge because preoperative screening including Pap cytology and pelvic ultrasonography often yields normal findings. A 52-year-old perimenopausal woman (P2L2) presented with irregular menstrual cycles and intermenstrual spotting. Speculum examination revealed a large, pedunculated cervical polyp measuring approximately 5 cm. Both preoperative cervical cytology (NILM) and transvaginal ultrasound were reassuring. The patient underwent polypectomy, dilation and curettage (D&C), and endocervical curettage. Histopathological examination revealed sheets of highly dysplastic cells infiltrating vascular stroma with atypical mitosis. Immunohistochemistry (IHC) demonstrated carcinoma foci along with atypical stromal cell proliferation favoring a low-grade endometrial stromal sarcoma (ESS) with focal high-grade sarcomatous change. Stalk margins showed no lymphovascular invasion. Following multidisciplinary team (MDT) review and staging pelvic MRI/chest CECT showing no distant disease or residual invasion, total laparoscopic hysterectomy with bilateral salpingo-oophorectomy was performed. Final pathology showed no residual malignancy, and the patient remains disease-free under regular surveillance. Giant cervical polyps, even when presenting with benign physical characteristics and normal cytology/imaging, can harbor complex focal malignancies with mixed carcinomatous and sarcomatous components. Routine histopathological and immunohistochemical evaluation of all excised cervical lesions is essential for timely diagnosis and optimal oncologic management.
References
Kundu PR, Hooda S, Parul, Singh K, Agarwal R, Kaur S. Cervical polyp: histomorphological spectrum of ninety-two cases: a five-year study. Int J Reprod Contracept Obstet Gynecol. 2023;12(1):221–5.
Gupta S, Chadha S, Kalwaniya DS, Dhir B. Rare occurrence of adenocarcinoma in an endocervical polyp: diagnostic and clinical challenges. Int J Reprod Contracept Obstet Gynecol. 2024;13(11):3371–3.
Yousofzai BS, Walizada K, Ahmadi M, Ansari M, Latoui RB, Fatima M, et al. Prevalence, clinical features, and management of cervical polyps: a one-year study at Rabia Balkhi Hospital in Afghanistan. Cureus. 2024;16(9):e69417.
Levy RA, Kumarapeli AR, Spencer HJ, Quick CM. Cervical polyps: is histologic evaluation necessary? Pathol Res Pract. 2016;212(9):800–3.
Kaur A, Suman S, Batta N, Kumar R, Narang S. Case report of atypical presentation of carcinoma cervix: a giant cervical polyp. NMO Journal. 2025;19:236–8.
Berzolla CE, Schnatz PF, O'Sullivan DM, Bansal R, Mandavilli S, Sorosky JI. Dysplasia and malignancy in endocervical polyps. J Womens Health (Larchmt). 2007;16(9):1317–21.
Al-Hamdany MZ, Fadhil MS. Histological changes of endocervical polypoid lesions in women at reproductive age. Med J Babylon. 2024;21(1):165–9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Shinde Geeta Ratnakar, Prabhdeep Kaur, Neena Guha, Himani Gupta

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.